Neogen Corp (NEOG) Stock Price

NEOGStock

$11.64+105.67%52W

Market Cap$2.54B

P/E—

PEG Ratio0.66

Div yield—

Beta1.84

NEOG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-7.21%

Price vs S&P 500 (4W)23.17%

PEG Ratio0.66

VGM Score56.13

P/CF (Annual)30.35x

Book Value / Share (Quarterly)$9.61

P/TBV (Annual)2.51x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)1.91%

Cash Flow / Share (Quarterly)$0.15

Price vs S&P 500 (YTD)53.99%

Gross Margin (TTM)46.93%

Net Profit Margin (TTM)-0.91%

EPS (TTM)$-0.04

10-Day Avg Trading Volume1.59M

EPS Excl Extra (TTM)$-0.04

Revenue Growth (5Y)13.19%

EPS (Annual)$-0.04

ROI (Annual)-0.27%

Gross Margin (Annual)46.93%

Net Profit Margin (5Y Avg)-23.52%

Cash / Share (Quarterly)$0.85

Revenue Growth QoQ (YoY)-0.07%

ROA (Last FY)-0.24%

Revenue Growth TTM (YoY)-2.71%

EBITD / Share (TTM)$0.67

ROE (5Y Avg)-9.74%

Operating Margin (TTM)6.29%

Cash Flow / Share (Annual)$0.15

P/B Ratio1.21x

P/B Ratio (Quarterly)0.93x

Net Income / Employee (Annual)$-2,700

EV / Revenue (TTM)3.60x

Net Interest Coverage (TTM)0.86x

ROA (TTM)-0.23%

EV / EBITDA (TTM)21.38x

EPS Incl Extra (Annual)$-0.04

Current Ratio (Annual)3.82x

Quick Ratio (Quarterly)2.53x

3-Month Avg Trading Volume2.22M

52-Week Price Return105.67%

EV / Free Cash Flow (Annual)98.22x

Revenue / Employee (TTM)$292,700

Tangible BV / Share (Quarterly)$3.56

P/S Ratio (Annual)2.90x

Asset Turnover (Annual)0.26x

52-Week High$12.85

Operating Margin (5Y Avg)-18.05%

EPS Excl Extra (Annual)$-0.04

CapEx CAGR (5Y)13.94%

Tangible BV CAGR (5Y)0.71%

26-Week Price Return4.04%

Quick Ratio (Annual)2.53x

13-Week Price Return30.93%

Total Debt / Equity (Annual)0.38x

Current Ratio (Quarterly)3.82x

Enterprise Value$3.13B

Revenue / Share Growth (5Y)-1.76%

Asset Turnover (TTM)0.26x

Book Value / Share Growth (5Y)4.22%

Revenue / Employee (Annual)$292,700

Inventory Turnover (Annual)2.76x

Pretax Margin (Annual)-1.03%

Cash / Share (Annual)$0.85

3-Month Return Std Dev58.76%

Gross Margin (5Y Avg)47.94%

Net Income / Employee (TTM)$-2,700

EBITDA CAGR (5Y)12.43%

EBITDA Interim CAGR (5Y)-0.02%

ROE (Last FY)-0.38%

Net Interest Coverage (Annual)0.84x

EPS Basic Excl Extra (Annual)$-0.04

P/FCF (TTM)56.05x

Receivables Turnover (TTM)5.80x

EV / Free Cash Flow (TTM)98.22x

Total Debt / Equity (Quarterly)0.38x

EPS Incl Extra (TTM)$-0.04

Receivables Turnover (Annual)5.80x

ROI (TTM)-0.27%

P/S Ratio (TTM)2.90x

Pretax Margin (5Y Avg)-24.10%

Revenue / Share (Annual)$4.00

Tangible BV / Share (Annual)$3.56

Forward P/E37.35x

Free OCF CAGR (5Y)-10.12%

Price vs S&P 500 (52W)87.36%

Year-to-Date Return65.95%

5-Day Price Return0.26%

EPS Normalized (Annual)$-0.04

ROA (5Y Avg)-5.56%

Net Profit Margin (Annual)-0.91%

Month-to-Date Return-3.65%

Cash Flow / Share (TTM)$0.39

EBITD / Share (Annual)$0.79

Operating Margin (Annual)6.30%

LT Debt / Equity (Annual)0.38x

P/CF (TTM)30.35x

ROI (5Y Avg)-6.49%

LT Debt / Equity (Quarterly)0.38x

EPS Basic Excl Extra (TTM)$-0.04

P/TBV (Quarterly)2.51x

P/B Ratio (Annual)0.93x

Inventory Turnover (TTM)2.76x

Pretax Margin (TTM)-1.03%

Book Value / Share (Annual)$9.61

Price vs S&P 500 (13W)28.13%

Beta1.84x

P/FCF (Annual)79.16x

Revenue / Share (TTM)$4.00

ROE (TTM)-0.37%

52-Week Low$4.90

vGradeC

gGradeC

mGradeB

vgmGradeC

NEOG Earnings Surprise History

Q2 250.05est. 0.09

Q3 250.04est. 0.04

Q4 250.10est. 0.07

Q1 260.09est. 0.05

Q2 260.09est. 0.06

NEOG Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.91

4.00

3.91

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
NEOGNeogen Corp	C	C	B	$11.64
IDXXIdexx Laboratories Inc	D	B	C	$550.01
LNTHLantheus Holdings, Inc	C	B	B	$100.87
CLDXCelldex Therapeutics, Inc	F	F	B	$41.22
NTLAIntellia Therapeutics, Inc	D	D	C	$13.51
QDELQuidelOrtho Corporation Common Stock	C	C	C	$15.05
ACHVAchieve Life Sciences, Inc.	F	F	A	$8.17
TKNOAlpha Teknova, Inc. Common Stock	D	C	A	$7.46
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	F	$7.83
MYGNMyriad Genetics Inc	B	C	D	$3.19
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	$4.44
ICCCImmucell Corp	C	B	B	$9.84
QCLSQ/C Technologies, Inc. Common Stock	C	—	F	$2.44
TRIBTrinity Biotech plc	B	D	F	$9.71
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	B	$1.91
BMRABIOMERICA INC	B	D	D	$1.77
VNRXVolitionRx Limited	B	A	F	$0.38
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	D	$2.91
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	C	$0.01

About Neogen Corp

Neogen Corporation develops food and animal safety solutions, offering diagnostics to detect pathogens, toxins, allergens, and contaminants in food and animal feed. The company operates through two segments: food safety diagnostics and animal health products, which include veterinary pharmaceuticals, vaccines, instruments, and genomics testing services. Based in Lansing, Michigan, Neogen serves food processors and agricultural businesses seeking to ensure product safety and traceability.